Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4719811 | 1.00 | ALDH1A1 (0.36) | ALDH1A1SOAT1SMN1; SMN2GAACYP2C9 | |
| SCHEMBL4629209 | 0.82 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL4720668 | 0.82 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL28756531 | 0.81 | LMNA (0.37) | SMN1; SMN2 | |
| SCHEMBL4014963 | 0.75 | ALDH1A1 (0.43) | ALDH1A1SOAT1CYP2D6 | |
| SCHEMBL2330898 | 0.75 | ALDH1A1 (0.43) | ALDH1A1SOAT1CYP2D6 | |
| SCHEMBL3309610 | 0.74 | MAPT (0.37) | ALDH1A1 | |
| SCHEMBL1207220 | 0.74 | MAPT (0.37) | ALDH1A1 | |
| SCHEMBL9054793 | 0.73 | SLC6A2 (0.43) | ALDH1A1SOAT1 | |
| SCHEMBL2567582 | 0.73 | SLC6A2 (0.43) | ALDH1A1SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1917256-A2 | SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | Boehringer Ingelheim International GmbH (DE) | 2008-05-07 | — | — | EP | disclosed |
| WO-2007020261-A2 | SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-02-22 | — | — | WO | disclosed |